Pharmacotherapy in the perinatal period‐ an exploratory study in midwifery
- 44 Downloads
Objective: To gather information on the adherence to the Dutch national neonatal vitamin K policy and on the administration of prescription medication during labor by community midwives.Methods: A telephone questionnaire under community midwives in the North of the Netherlands.Results: In the main, the vitamin K practices follow the guidelines with respect to who receives the first dose and maintenance therapy. There is possibly underdosing. Midwives use their license to administer medicines during labor in moderation: 91% report to never use tocolytics, oxytocics or analgesics.Conclusion: In general, the national vitamin K policy is followed. Information gathered prospectively is needed on the use of pharmacotherapy by community midwives in the perinatal period.
Unable to display preview. Download preview PDF.
- 1.Smits ER, Sjauw M. Births by obstetric assistence and place of delivery, 1992. Maandber Gezondheid (Statistics Bureau) 1995 (14)2;16-27.Google Scholar
- 2.Wiegers TA, Keirse MJ, van der Zee J, Berghs GA. Outcome of planned home and planned hospital births in low risk pregnancies: prospective study in midwifery practices in The Netherlands. BMJ 1996;313:1309-13.Google Scholar
- 3.Ansell P, Roman E, Fear NT, Renfrew MJ. Vitamin K policies and midwifery practice: questionnaire survey. BMJ 2001;322:1148-52.Google Scholar
- 4.Uitentuis J. Toediening van vitamine K aan pasgeborenen en zuigelingen [Administration of vitamin K to neonates and infants]. Ned Tijdschr Geneeskd 1990;134:1642-6.Google Scholar
- 5.Reerink JD. Vitamine K-toediening aan pasgeborenen toont regionale verschillen [Regional differences in vitamin K administration]. Ned Tijdschr Geneeskd 1990;134:397-8.Google Scholar
- 6.Ciba-Geigy. Wissenschaftliche Tabellen Geigy Teilband Statistik. 8th ed. Basel: Ciba-Geigy, 1980:90.Google Scholar
- 7.Tin W, Wariyar U, Hey E. Preventing late bleeding in infants with vitamin K deficiency. BMJ 1998;316:230.Google Scholar
- 8.Cornelissen M, von Kries R, Loughnan P, Schubiger G. Prevention of vitamin K deficiencey bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr 1997;156:126-130. Appendix Questions asked with respect to pharmacotherapy 1. Do you give Vitamin K to all newborns? If 1 answered by ‘no': What considerations do determine whether you do or do not give vitamin K? 2. Do you give the first dose orally or intramuscular? If 2 answered by ‘both': In what percentage of newborns do you use these routes? In which cases do you use intramuscular administration? 3. What first dose vitamin K do you give? 4. Do you explain and give parents a prescription for the mainenaince therapy? If 4 answered ‘yes’ or sometimes: What considerations do determine whether you do or do not give a prescription? 5. What dose do you recommend for the maintenance therapy? Now we'd like to ask you some questions with regard to medication in the perinatal period 6. Do you use tocolytics? If yes, could you estimate the percentage of cases in which you do use tocolytics? 7. Do you use oxytocics? If yes, could you estimate the percentage of cases in which you do use oxytoctics? 8. Do you use analgesics? If yes, could you estimate the percentage of cases in which you do use analgesics? 9. Do you use local aneasthesia? If yes, could you estimate the percentage of cases in which you do use local aneasthesia? 10. Do you use medicines for stopping post-partum hemorrhages? If yes, could you estimate the percentage of cases in which you do these? 11. Do you use other medicines? If yes, could you estimate the percentage of cases in which you do use other medicines? What type of medicines are these? Pharmacy World & Science Volume 23 No. 6 2001 226Google Scholar